Matching Biomarkers to Disease Biology & Therapy
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
In this interview with researcher & surgical oncologist Dr. Jason Sicklick shares about his passion for SDH-deficient GIST research.
UC San Diego Health released a post today titled, "Genetic Testing Cost Effective for Newly Diagnosed GIST" discussing a new paper published in JAMA Network Open by Moores Cancer Center's Dr. Jason Sicklick and colleagues which covered genetic testing for GIST patients.
PICTURED: Dr. Jason Sicklick, Deb Melikian,Norman Scherzer, & Malcolm Aste Record numbers attended our GIST Day of Learning on July 15th in La Jolla, California. Over 100 people gathered to [...]
It's not too late to sign up for the GIST Day of Learning (GDOL) in La Jolla/San Diego on July 15th. We are very excited to have some of the top GIST experts present [...]
On July 13th, the Life Raft Group will be celebrating the third annual GIST Awareness Day! Every year, our goal is to increase awareness about GIST worldwide. This year, we are celebrating GAD with our [...]
Jason Sicklick, M.D Recent findings from a population-based retrospective cohort study at the at Moores Cancer Center at UC San Diego Health, led by senior author, Jason Sicklick, M.D., indicate that small [...]
New York, NY and Wayne, NJ - January 12, 2017 Columbia University Medical Center, NewYork-Presbyterian and the Life Raft Group (LRG), a patient advocacy organization specializing in GIST cancer, announced today that they have [...]
Dr. Jason Sicklick On Saturday, January 24, the Moores Cancer Center in sunny San Diego played host to the first of our 2015 GIST Days of Learning. Nearly fifty GIST patients, caregivers, family [...]